About Enamine
Enamine is a company based in Kyiv (Ukraine) founded in 1991.. Enamine offers products and services including Building Blocks Catalog, Compound Libraries, and Custom Synthesis. Enamine operates in a competitive market with competitors including Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others.
- Headquarter Kyiv, Ukraine
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enamine Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2.35 M (USD), Grant
Apr 01, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enamine
Enamine offers a comprehensive portfolio of products and services, including Building Blocks Catalog, Compound Libraries, and Custom Synthesis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catalog of over 300 thousand compounds for synthesis and research.
Pre-plated libraries for targeted drug discovery applications.
Tailored chemical synthesis using advanced technologies.
Unlock access to complete
Funding Insights of Enamine
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.4M
-
First Round
First Round
(01 Jan 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Grant - Enamine | Valuation |
investors |
|
| Mar, 2021 | Amount | Grant - Enamine | Valuation |
investors |
|
| Jan, 2021 | Amount | Grant - Enamine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enamine
Enamine has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enamine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enamine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enamine Comparisons
Competitors of Enamine
Enamine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sai Life Sciences, Acies Bio, Personal Chemistry, IRBM and NFIL, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
|
|
| domain | founded_year | HQ Location |
Coherent Synthesis is developed for medicinal and combinatorial chemistry applications.
|
|
| domain | founded_year | HQ Location |
Integrated drug discovery and preclinical development services are provided.
|
|
| domain | founded_year | HQ Location |
Fluorinated compounds are synthesized and manufactured customly for various industries.
|
|
| domain | founded_year | HQ Location |
Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enamine
Frequently Asked Questions about Enamine
When was Enamine founded?
Enamine was founded in 1991 and raised its 1st funding round 25 years after it was founded.
Where is Enamine located?
Enamine is headquartered in Kyiv, Ukraine.
Who is the current CEO of Enamine?
David Leahy is the current CEO of Enamine.
What does Enamine do?
Enamine is a drug discovery CRO offering a range of products and services for facilitating drug discovery and preclinical development. Their major products include screening compounds and building blocks which include over 2.2 million compounds (which include 27,000 fragments and 175,000 building blocks), while their major services include custom synthesis, lead optimization, and molecular modeling. Enamine has several compound libraries for fragment-based drug discovery (Rule of three, Golden fragment, fluorinated, brominated libraries, among several others), focused and targeted drug discovery (Ex: CNS-targeted, Nuclear receptor and Ion-channel libraries, among several others) and express lead-based drug discovery (novel lead-like libraries synthesised and delivered in 2-3 weeks). Enamines service portfolio includes Hit Follow-Up Support, Custom synthesis (Small molecules, intermediates, reference compounds, fragment libraries etc), bioanalytical and HTS screening services (through its subsidiary Bienta, which offers in vitro ADMET and pharmacokinetic assays (biochemical and cell-based assays)). Enamine has a partnership with Ukrainian company FCH Group for compound library synthesis. Actelions RD Spinoff, RD NewCo signed an agreement with Enamine in January 2017 for access to its novel building blocks and screening libraries for use in early drug discovery.
Who are the top competitors of Enamine?
Enamine's top competitors include Sai Life Sciences, Acies Bio and Liverpool ChiroChem.
What products or services does Enamine offer?
Enamine offers Building Blocks Catalog, Compound Libraries, and Custom Synthesis.
Who are Enamine's investors?
Enamine has 1 investor. Key investors include European Union.